Cardiac Science Appoints Todd Alberstone as General Counsel

Jan 12, 2010, 06:00 ET from Cardiac Science Corporation

BOTHELL, Wash., Jan. 12 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices that connect to electronic medical record (EMR) and hospital information systems, appointed Todd Alberstone as vice president and general counsel, effective immediately. In this new role, Mr. Alberstone will report to Dave Marver, president and chief executive officer, and will oversee all of the Company's legal affairs.


"Todd has an outstanding background in technology and intellectual property law," said Dave Marver, Cardiac Science president and chief executive officer. "In addition to helping us be more efficient in our legal spending, Todd will bring strength to our business and the strategic management of our IP portfolio."

Mr. Alberstone, 50, has held positions as director of intellectual property management for the University of Washington, associate general counsel for Real Networks, adjunct professor at Southwestern University School of Law, as well as positions in private practice. Mr. Alberstone has an undergraduate degree in economics from the University of California, Berkeley, and received his J.D. from the University of California, Berkeley (Boalt Hall).

In connection with Mr. Alberstone's hiring, the compensation committee of the Company's board of directors approved an inducement grant made outside of the Company's 2002 Equity Incentive Plan pursuant to which Mr. Alberstone has been awarded, effective as of close of business Jan. 11, 2010, 50,000 restricted common stock units. These restricted stock units vest 25 percent after one year of service and an additional 25 percent after each additional year of service thereafter, until fully vested.

About Cardiac Science:

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress test treadmills and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, vital signs monitors, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at, Twitter at, Facebook at, YouTube at

For more information,

Company Contact:

Investor Contact:

Media Contact:

Mike Matysik

Cardiac Science Corporation

Senior Vice President and CFO


Matt Clawson

Allen & Caron


Christopher Gale

EVC Group Inc.





SOURCE Cardiac Science Corporation